← Back to Search

Procedure

CPAP Therapy for Sleep Apnea

N/A
Recruiting
Led By Dr. Julio Furlan
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Individuals with a cervical or thoracic, complete or incomplete (AIS A to D), chronic (> 6 months) SCI
English-speaking adults (18 years of age or older)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in sf-36 from baseline to after 4-month period of cpap therapy
Awards & highlights

Study Summary

This trial will investigate if continuous positive airway pressure (CPAP) therapy can help improve cognitive function and overall quality of life for para-athletes with spinal cord injuries and sleep-related breathing disorders.

Who is the study for?
This trial is for para-athletes in Ontario with spinal cord injuries who have moderate-to-severe sleep-related breathing disorders. Participants should be experiencing issues like cognitive impairment, fatigue, depression, or anxiety and are looking to improve their quality of life and sports performance.Check my eligibility
What is being tested?
The study is testing if CPAP therapy can help these athletes by improving mental sharpness, reducing tiredness and negative feelings, enhancing overall well-being, and lowering the chance of sports injuries.See study design
What are the potential side effects?
CPAP therapy may cause side effects such as discomfort or irritation where the mask touches the face, dry nose or throat, headaches, excessive dreaming during early use, stomach bloating and leaks around the mask.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had a spinal cord injury in my neck or upper back for more than 6 months.
Select...
I am 18 or older and speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in sf-36 from baseline to after 4-month period of cpap therapy
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in sf-36 from baseline to after 4-month period of cpap therapy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acute Recovery and Stress Scale (ARSS)
Craig Handicap Assessment and Recording Technique
Depression, Anxiety & Stress Scales- 21
+7 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: CPAP TherapyExperimental Treatment1 Intervention
Participants who are diagnosed with moderate-to-severe sleep related breathing disorders (SRBDs) will undergo a 4-month trial of Continuous positive airway pressure (CPAP) therapy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CPAP Therapy
2008
N/A
~160

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,476 Previous Clinical Trials
485,165 Total Patients Enrolled
4 Trials studying Sleep Apnea
364 Patients Enrolled for Sleep Apnea
Sunnybrook Health Sciences CentreOTHER
656 Previous Clinical Trials
1,551,292 Total Patients Enrolled
2 Trials studying Sleep Apnea
810 Patients Enrolled for Sleep Apnea
Dr. Julio FurlanPrincipal InvestigatorUniversity Health Network, Toronto

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment process currently in progress for participants of this research study?

"According to the information available on clinicaltrials.gov, this specific clinical trial is not currently seeking participants. The initial posting date was on January 1st, 2024, and the most recent update occurred on December 24th, 2023. However, it's important to note that there are currently 1318 other ongoing clinical trials actively recruiting patients at this time."

Answered by AI
~10 spots leftby Aug 2025